EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A transformer-based deep learning survival prediction model and an explainable XGBoost anti-PD-1/PD-L1 outcome prediction model based on the cGAS-STING-centered pathways in hepatocellular carcinoma

Ren Wang, Qiumei Liu, Wenhua You, Huiyu Wang, Yun Chen iD

Briefings in Bioinformatics · 2024

DOI: 10.1093/bib/bbae686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2024. Verfasst von Ren Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Department of Immunology, School of…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Deep Learning, B7-H1 Antigen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Jiangsu Provincial Key Research Development Program of China, Major Program of Wuxi Medical Center, Nanjing Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent studies suggest cGAS-STING pathway may play a crucial role in the genesis and development of hepatocellular carcinoma (HCC), closely associated with classical pathways and tumor immunity. We aimed to develop models predicting survival and anti-PD-1/PD-L1 outcomes centered on the cGAS-STING pathway in HCC. We identified classical pathways highly correlated with cGAS-STING pathway and constructed transformer survival model preserving raw structure of pathways. We also developed explainable XGBoost model for predicting anti-PD-1/PD-L1 outcomes using SHAP algorithm. We trained and validated transformer survival model on pan-cancer cohort and tested it on three independent HCC cohorts. Using 0.5 as threshold across cohorts, we divided each HCC cohort into two groups and calculated P values with log-rank test. TCGA-LIHC: C-index = 0.750, P = 1.52e−11; ICGC-LIRI-JP: C-index = 0.741, P = .00138; GSE144269: C-index = 0.647, P = .0233. We trained and validated [area under the receiver operating characteristic curve (AUC) = 0.777] XGBoost model on immunotherapy datasets and tested it on GSE78220 (AUC = 0.789); we also tested XGBoost model on HCC anti-PD-L1 cohort (AUC = 0.719). Our deep learning model and XGBoost model demonstrate potential in predicting survival risks and anti-PD-1/PD-L1 outcomes in HCC. We deployed these two prediction models to the GitHub repository and provided detailed instructions for their usage: deep learning survival model, https://github.com/mlwalker123/CSP_survival_model; XGBoost immunotherapy model, https://github.com/mlwalker123/CSP_immunotherapy_model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsDeep LearningB7-H1 AntigenMembrane ProteinsProgrammed Cell Death 1 ReceptorNucleotidyltransferasesHumansPrognosisImmune Checkpoint InhibitorsSignal TransductionAlgorithmsSTING ProteinCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Stichwörter der Autor:innen

cGAS-STING pathwaydeep learningexplainable modelhepatocellular carcinoma

Substanzen

B7-H1 AntigenMembrane ProteinsProgrammed Cell Death 1 ReceptorNucleotidyltransferasesImmune Checkpoint InhibitorsSTING1 protein, humanSTING ProteincGAS protein, humanCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthasePDCD1 protein, human

Autor:innen und Institutionen

  • The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Department of Immunology, School of Basic Medical Sciences, Nanjing Medical University, 101 Longmian Aven…
  • The Affiliated Huai'an No. 1 People's Hospital, Nanjing Medical University, West Road of the Yellow River, Huai'an 223300, Jiangsu Province, China.
  • Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, Jiangsu Province, China.

ORCID-Profile: Yun Chen

Förderung

  • National Natural Science Foundation of China
  • Jiangsu Provincial Key Research Development Program of China
  • Major Program of Wuxi Medical Center, Nanjing Medical University
  • Taihu Light Science and Technology Project of Wuxi

Zitieren

APA

Wang, R., Liu, Q., You, W., Wang, H., & Chen, Y. (2024). A transformer-based deep learning survival prediction model and an explainable XGBoost anti-PD-1/PD-L1 outcome prediction model based on the cGAS-STING-centered pathways in hepatocellular carcinoma. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbae686

Vancouver

Wang R, Liu Q, You W, Wang H, Chen Y. A transformer-based deep learning survival prediction model and an explainable XGBoost anti-PD-1/PD-L1 outcome prediction model based on the cGAS-STING-centered pathways in hepatocellular carcinoma. Briefings in Bioinformatics. 2024. doi:10.1093/bib/bbae686

BibTeX
@article{Wang2024,
  author = {Wang, Ren and Liu, Qiumei and You, Wenhua and Wang, Huiyu and Chen, Yun},
  title = {A transformer-based deep learning survival prediction model and an explainable XGBoost anti-PD-1/PD-L1 outcome prediction model based on the cGAS-STING-centered pathways in hepatocellular carcinoma},
  journal = {Briefings in Bioinformatics},
  year = {2024},
  doi = {10.1093/bib/bbae686}
}
Kostenlos starten →